Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

A case of mediastinitis following botulinum toxin type A treatment for achalasia

Abstract

Background A 62-year-old obese, diabetic female underwent endoscopic esophageal injection of botulinum toxin type A (Botox®; Allergan, Irvine, CA) for achalasia. The patient presented to her gastroenterologist with chest pain 4 days after the procedure, but no thoracic or gastrointestinal pathologies were identified and the patient was sent home. She presented again the next day with continuing chest pain and newly developed fever. Esophagoduodenoscopy revealed no esophageal leak and a CT scan revealed only mild paraesophageal inflammation. The patient was sent home the same day with antibiotics after a urinalysis suggested presence of a urinary tract infection. The patient presented again 9 days after the procedure with continuing chest pain and fever.

Investigations Chest radiography, electrocardiography, complete blood count, cardiac enzyme levels, basic metabolic panel, urinalysis, Gastrografin® (Bracco Diagnostics Inc, Princeton, New Jersey) and barium swallow study, endoscopy, abdominal and chest CT scans, blood culture and wound culture.

Diagnosis Ulceration without perforation of the esophageal mucosa in the area of Botox® injections. Unilateral pleural effusion and mediastinitis without abscess formation.

Management Pantoprazole and clonazepam for suspected gastroesophageal reflux and esophageal spasm. Levofloxacin for urinary tract infection. Intravenous antibiotic therapy and acute surgical exploration for possible esophageal rupture. Paraesophageal drain placement, nasogastric tube placement, and parenteral and enteral feeding.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Chest CT scan taken 9 days after the patient received Botox® (Allergan, Irvine, CA) injections for achalasia.
Figure 2: Esophagoduodenoscopy image of the case patient's esophagus performed 13 days after Botox® (Allergan, Irvine, CA) injections for achalasia.

References

  1. Eaker EY et al. (1997) Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia. Dig Dis Sci 42: 724–727

    Article  CAS  Google Scholar 

  2. Tintillier M et al. (2004) Esophageal abscess complicating endoscopic treatment of refractory gastroesophageal reflux disease by Enteryx injection: a first case report. Am J Gastroenterol 99: 1856–1858

    Article  Google Scholar 

  3. Schuman BM et al. (1987) Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol 82: 823–830

    CAS  PubMed  Google Scholar 

  4. Fitzgerald JF et al. (2002) Clinical quiz. Sinus tract between esophagus and fundus. J Pediatr Gastroenterol Nutr 35: 38, 98

    Article  Google Scholar 

  5. Andrews CN et al. (1999) Laparoscopic Heller's myotomy or botulinum toxin injection for management of esophageal achalasia. Patient choice and treatment outcomes. Surg Endosc 13: 742–746

    Article  CAS  Google Scholar 

  6. Jankovic J and Brin MF (1991) Therapeutic uses of botulinum toxin. N Engl J Med 324: 1186–1194

    Article  CAS  Google Scholar 

  7. Pasricha PJ et al. (1995) Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 332: 774–778

    Article  CAS  Google Scholar 

  8. Hurwitz M et al. (2000) Evaluation of the use of botulinum toxin in children with achalasia. J Pediatr Gastroenterol Nutr 30: 509–514

    Article  CAS  Google Scholar 

  9. Kolbasnik J et al. (1999) Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study. Am J Gastroenterol 94: 3434–3439

    Article  CAS  Google Scholar 

  10. D'Onofrio V et al. (2002) Long-term follow-up of achalasia patients treated with botulinum toxin. Dig Liver Dis 34: 105–110

    Article  CAS  Google Scholar 

  11. Neubrand M et al. (2002) Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy 34: 519–523

    Article  CAS  Google Scholar 

  12. Zaninotto G et al. (2004) Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: economic analysis of a randomized trial. Surg Endosc 18: 691–695

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robroy Mac Iver.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iver, R., Liptay, M. & Johnson, Y. A case of mediastinitis following botulinum toxin type A treatment for achalasia. Nat Rev Gastroenterol Hepatol 4, 579–582 (2007). https://doi.org/10.1038/ncpgasthep0951

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0951

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing